Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."

Randy Maloziec featured in Rare Disease Report article: "Fostamatinib Disodium Hexahydrate Tablet to Be Dispensed by US Bioservices for ITP"

Rigel Pharmaceuticals has recently selected US Bioservices to dispense fostamatinib disodium hexahydrate (TAVALISSE) tablets, for the treatment of adult patients with chronic immune thrombocytopenia (ITP), a rare blood disorder, who have had an insufficient response to a previous treatment.